Qiagen N.V. (QGEN:NYSE) closed at $50.39 on October 23, 2026, up 0.34% on the day. The stock trades 12.9% below its 52-week high of $57.82 and 54.9% above its 52-week low of $32.53. Over the past year, it gained 2.2%. Qiagen N.V. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
In 252 trading sessions since October 23, 2025, QGEN closed higher on 113 days (45%). Its best day was January 20, 2026 (+16.57%) and its worst was April 28, 2026 (-10.69%). The stock moved 10% or more in a single session 3 times.
QIAGEN N.V. provides sample to insight solutions that transform biological materials into valuable molecular insights worldwide. It offers sample technologies for plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, and library preparation for sequencing applications; and assay technology solutions. The company provides Ingenuity Variant Analysis, a cloud-based platform that interprets data from next-generation sequencing (NGS) analysis; QIAGEN Clinical Insight, an evidence-based decision support solution; CLC Genomics Workbench for the analysis and visualization of data from various NGS platforms; and GeneGlobe, a Web-based portal that enables researchers to search and select gene- and pathway-specific solutions from pre-designed and custom PCR assay kits, NGS assay panels, and other products. It also offers instrumentation systems for laboratories to perform nucleic acid sample preparation, assay setup, target detection, and interpretation of genomic information. The company's automation platforms include QIAsymphony, a modul...
Find more stocks like QGEN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.